Grifols to help Saudi Arabia produce blood plasma medicines
Spanish pharmaceutical company
Grifols said on Tuesday it had signed a non-binding
agreement with Saudi Arabia’s sovereign wealth fund to help the
country produce blood plasma-derived medicines.